α-Synuclein aggregates inhibit ESCRT-III through sequestration and collateral degradation

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Alpha-synuclein aggregation is central to Parkinson's disease and synucleinopathies.
• Extracellular alpha-synuclein fibrils enter cells and seed aggregation, sequestering cellular proteins.
• The toxic effects of sequestered proteins, particularly ESCRT-III, are not well understood.

Purpose of the Study:

• To investigate the toxic mechanisms by which alpha-synuclein fibrils impact cellular protein homeostasis.
• To elucidate the interaction between alpha-synuclein fibrils and the endosomal sorting complexes required for transport (ESCRT)-III system.
• To understand the role of ESCRT-III sequestration in driving disease progression.

Main Methods:

• Utilized cellular models to study alpha-synuclein fibril uptake and intracellular effects.
• Employed in vitro reconstitution assays to define molecular interactions.
• Analyzed protein degradation pathways, specifically proteasomal destruction.

Main Results:

• Alpha-synuclein fibrils bind to a conserved alpha-helix in ESCRT-III proteins.
• This interaction leads to "collateral degradation" and depletion of the ESCRT-III protein pool.
• Loss of ESCRT-III function impairs endolysosome membrane repair, promoting further aggregation.

Conclusions:

• Collateral degradation and self-perpetuating sequestration systems are key mechanisms of proteotoxicity.
• Disruption of the ESCRT-III system by alpha-synuclein contributes to Parkinson's disease pathogenesis.
• Targeting these sequestration-induced toxic pathways may offer therapeutic strategies.